Joshua J. Todd, Ph.D., M.B.A

Dr. Todd is a Scientific Director, Clinical Development at Neurocrine Biosciences Inc., a neuroscience-focused biopharmaceutical company based in San Diego, California. Following his doctoral training in the UK, Dr. Todd was recruited to the NIH Intramural Program where he served as an investigator on the first two clinical trials for RYR1-related disorders (NAC and Rycals) and a prospective natural history study. As a former member of Dr. Carsten Bönnemann’s team and the Clinical Trials Unit at the NIH/NINDS, Dr. Todd also led the clinical development of gene and transcript-directed therapies for a wide range of neurological disorders and received independent research funding from The RYR-1 Foundation and Muscular Dystrophy Association.